Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
All content for Trends from the Trenches is the property of Bio-IT World and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
Episode: 34 - Discussing HPCs and Research Computing With Dirk Petersen
Trends from the Trenches
29 minutes
8 months ago
Episode: 34 - Discussing HPCs and Research Computing With Dirk Petersen
In the first Trends from the Trenches episode of 2025, host Stan Gloss and Dirk Petersen, Director of Supercomputing Center at Oregon State University, talk about the state and role of HPCs in a world that’s focused on AI. Petersen offers his thoughts and insights on working with AI teams, how to converge the traditional HPC user with the AI user, the “Wild West” of AI infrastructure and computing power, and how AI is driving a renaissance in scientific computing and high-performance computin...
Trends from the Trenches
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
